JDD Online News

Exclusive dermatology updates brought to you by the Journal of Drugs in Dermatology (JDD) online editorial team.  Stay up-to-date on dermatology and aesthetic news, conference coverage, featured articles and more.

Journal of Drugs in Dermatology JDD Article About A Guide to Informed Skincare: The Meaning of Clean, Natural, Organic, Vegan, and Cruelty-Free

A Guide to Informed Skincare: The Meaning of Clean, Natural, Organic, Vegan, and Cruelty-Free

| Featured Articles, Latest News, Skincare, The Latest | No Comments
"Clean," "Natural," "Cruelty-Free": Why Your Patients Are Asking—and What You Need to Know With the rise of “clean beauty,” more patients are coming to dermatology visits with questions about the…
Journal of Drugs in Dermatology JDD Article About Topical Corticosteroid Potencies: Reimagining A New Universal Classification System

Topical Corticosteroid Potencies: Reimagining A New Universal Classification System

| Featured Articles, Latest News, The Latest | No Comments
Time for a Global Standard? Rethinking Topical Corticosteroid Classification Topical corticosteroids (TCS) are a mainstay in dermatology, used to treat a wide range of skin conditions. While effective and generally…
Journal of Drugs in Dermatology JDD Article About The Comparison Between Conventional Photodynamic Therapy and "Painless" Photodynamic Therapy in the Treatment of Actinic Keratosis: A Mini Review. Image from the Full Spectrum of Dermatology: A Diverse and Inclusive Atlas of a light skin tone person with actinic keratosis and erythema.

The Comparison Between Conventional Photodynamic Therapy and “Painless” Photodynamic Therapy in the Treatment of Actinic Keratosis: A Mini Review

| Featured Articles, Latest News, The Latest | No Comments
Photodynamic Therapy for Actinic Keratosis: Can We Make It Painless? Actinic keratosis (AK), a common result of sun damage, can be a warning sign for squamous cell carcinoma. With skin…
Journal of Drugs in Dermatology JDD Article About A Review of the Role of C. Acnes and its Biofilm in Dandruff Pathogenesis. Image from the Full Spectrum of Dermatology: A Diverse and Inclusive Atlas featuring a woman with a deep skin tone with acne on her cheek. Post inflammatory hyperpigmentation is present.

Post-Isotretinoin Acne Management: A Pilot Survey of the American Acne and Rosacea Society Board of Directors

| Acne, Featured Articles, Latest News, The Latest | No Comments
What Happens After Isotretinoin? New Insights Into Post-Treatment Acne Care Isotretinoin remains the gold standard for treating severe acne, but relapse after treatment is common, affecting 20 to 60% of…
Journal of Drugs in Dermatology JDD Article About A Review of the Role of C. Acnes and its Biofilm in Dandruff Pathogenesis

A Review of the Role of C. Acnes and its Biofilm in Dandruff Pathogenesis

| Featured Articles, Hair, Latest News, The Latest | No Comments
The Hidden Role of C. acnes in Dandruff: Beyond the Flakes Dandruff affects nearly 50% of the global population, yet its exact causes remain under ongoing investigation. While most clinicians…
Journal of Drugs in Dermatology JDD Article About Weight Change and Dose Adjustment in Isotretinoin Therapy: A Retrospective Study

Weight Change and Dose Adjustment in Isotretinoin Therapy: A Retrospective Study

| Featured Articles, Latest News, The Latest | No Comments
Isotretinoin Dosing in Adolescents: Does Weight Change Matter? Isotretinoin remains the gold standard for treating severe nodulocystic acne, with cumulative dosing of 120-150 mg/kg shown to balance safety and efficacy. Higher…

JDD in the News: Upadacitinib’s Potential Cardiovascular Effects 

| Acne, Derm Community, Featured Articles, JDD Highlights, JDD in the Media, The Latest | No Comments
Upadacitinib may provide additional health benefits, including reducing the risk of major adverse cardiovascular events (MACE) and venous thromboembolism (VTE). That’s according to a May Journal of Drugs in Dermatology…
Journal of Drugs in Dermatology JDD Article About Need for Speed: Topical Roflumilast for Rapid Control of Seborrheic Dermatitis Flares

Need for Speed: Topical Roflumilast for Rapid Control of Seborrheic Dermatitis Flares

| Featured Articles, Latest News, The Latest | No Comments
Faster Relief for Seborrheic Dermatitis? A Case for Topical Roflumilast Seborrheic dermatitis is a chronic inflammatory skin condition that often frustrates patients and clinicians alike, especially during flare-ups. While topical corticosteroids…

Dermatology Roundup: Survey Shows Misconceptions About Sunscreen and Skin Aging

| JDD Highlights, JDD in the Media, The Latest | No Comments
By Allison Sit A new American Academy of Dermatology (AAD) survey shows American adults may not fully understand the benefits of sunscreen. The survey of 1,000 adults found nearly one…
Journal of Drugs in Dermatology JDD Article About Cutaneous Immune-Related Adverse Events Associated With Immunotherapy in Patients With Melanoma

Cutaneous Immune-Related Adverse Events Associated With Immunotherapy in Patients With Melanoma

| Featured Articles, Latest News, Skin Cancer, The Latest | No Comments
What Skin Toxicities May Signal in Melanoma Patients on Immunotherapy Cutaneous immune-related adverse events (irCAEs) are among the most common side effects seen in patients receiving immune checkpoint inhibitors (ICIs)…
Journal of Drugs in Dermatology JDD About The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas. The images is of keloid among different skin tones

Decoding Derm: What’s the Diagnosis?

| Featured Articles, Inclusive Derm Atlas, Inclusive Dermatology Atlas, Latest News, The Latest | No Comments
Test Your Knowledge!  Join Dr. Alexis Carrington, Chief Dermatology Resident at George Washington University, to help understand dermatologic conditions across all skin tones. Decoding Derm: What’s the Diagnosis is a…
Journal of Drugs in Dermatology JDD Article About The Comparison Between Conventional Photodynamic Therapy and “Painless” Photodynamic Therapy in the Treatment of Actinic Keratosis: A Mini Review

The Comparison Between Conventional Photodynamic Therapy and “Painless” Photodynamic Therapy in the Treatment of Actinic Keratosis: A Mini Review

| Featured Articles, Latest News, Skin Cancer, The Latest | No Comments
Painless™ PDT vs. Conventional PDT: A Quick Look at Patient Comfort in AK Treatment Actinic keratosis (AK) is one of the most common conditions treated by dermatologists, and photodynamic therapy…
Journal of Drugs in Dermatology JDD Article About Exploring the Scope of Melanoma Educational Content on Instagram

Exploring the Scope of Melanoma Educational Content on Instagram

| Featured Articles, Latest News, Skin Cancer, The Latest | No Comments
Melanoma Education on Instagram: What’s Missing—Especially for Skin of Color As melanoma rates rise, with a projected 7.3% increase in new cases and 3.8% rise in mortality in 2024, the…
Journal of Drugs in Dermatology JDD Article About Squamous Cell Carcinoma In Situ on High-Risk Sites and With Larger Sizes Require More Stages for Clearance With Mohs Surgery

Squamous Cell Carcinoma In Situ on High-Risk Sites and With Larger Sizes Require More Stages for Clearance With Mohs Surgery

| Featured Articles, Latest News, Skin Cancer, The Latest | No Comments
What to Expect When Treating SCC In Situ with Mohs Surgery While squamous cell carcinoma in situ (SCCIS) is typically considered a low-risk skin cancer, treatment decisions, especially around surgical…
Journal of Drugs in Dermatology JDD Article About Endocrine Mucin Producing Sweat Gland Carcinoma Treated With Mohs Micrographic Surgery: A Systematic Review

Endocrine Mucin Producing Sweat Gland Carcinoma Treated With Mohs Micrographic Surgery: A Systematic Review

| Featured Articles, Latest News, Skin Cancer, The Latest | No Comments
EMPSGC: Why Mohs Might Be the Better Choice Endocrine Mucin Producing Sweat Gland Carcinoma (EMPSGC) is rare, low-grade, and slow-growing—but it’s not without risk. Though uncommon, recurrence and even distant…

What’s Old is New: The Translational Understanding of and Approaches to Dermatoporosis

| JDD Highlights, JDD Webinars, The Latest | No Comments
This webinar delves into the emerging field of dermatoporosis, a chronic skin fragility condition. Participants will explore the latest translational research that bridges basic science and clinical practice, enhancing our…
Journal of Drugs in Dermatology JDD Article About Safety of Topical Dermatologic Medications in Pregnancy: What You Need to Know

Safety of Topical Dermatologic Medications in Pregnancy: What You Need to Know

| Featured Articles, Latest News, The Latest | No Comments
From the Vault As more patients turn to the internet for guidance on pregnancy-safe skincare, dermatologists are increasingly fielding questions about what’s safe to use during pregnancy. One JDD article,…
Journal of Drugs in Dermatology JDD Article About Successful Treatment of Sacral Pressure Injury With ACU-D1

Successful Treatment of Sacral Pressure Injury With ACU-D1

| Featured Articles, Latest News, The Latest | No Comments
Could Proteasome Inhibitors Offer a New Option for Pressure Injuries? Pressure injuries, especially in the sacral area, are a frequent and frustrating challenge, particularly in elderly patients. Standard care focuses…
Journal of Drugs in Dermatology series Decoding Derm: What's the Diagnosis with Dr. Alexis Carrington. Topic is melanoma.

Decoding Derm: What’s the Diagnosis? National Melonoma and Skin Cancer Awareness Month

| Featured Articles, Inclusive Derm Atlas, Inclusive Dermatology Atlas, Latest News, Rosacea, The Latest | No Comments
In acknowledgement of National Melonoma and Skin Cancer Awareness Month, we are rerunning this series of Decoding Derm. Join Dr. Alexis Carrington in Decoding Dermatology: What’s the Diagnosis, as she presents a…
Journal of Drugs in Dermatology JDD Article About Current Landscape of Hyaluronic Acid Filler Use in the United States

JDD Article on HA Fillers Gets a Beauty Spotlight—Here’s Why Dermatologists Should Take Note

| Aesthetics, Featured Articles, Latest News, The Latest | No Comments
Knowledge is Critical for Successful Outcomes: Current Landscape of Hyaluronic Acid Filler Use in the United States   When a recent article of Allure recently explored the science behind “medical-grade”…
Journal of Drugs in Dermatology JDD Article About Video Abstract For Racial and Ethnic Representation in Atopic Dermatitis Clinical Trial.

Don’t Miss a Beat with JDD Corner — Starting with This Must-Watch Video Abstract on Atopic Dermatitis

| Featured Articles, JDD Corner, JDD Highlights, Latest News, The Latest | No Comments
WATCH NOW: Racial and Ethnic Representation in Atopic Dermatitis Clinical Trials With content flying at us from every direction, it’s easy to miss what matters most. That’s why JDD Corner…
Journal of Drugs in Dermatology JDD Article About The Impact of Geographic Dermatologist Density on Melanoma Mortality

The Impact of Geographic Dermatologist Density on Melanoma Mortality

| Featured Articles, Latest News, Skin Cancer, The Latest | No Comments
Melanoma Mortality Drops Where Dermatologists Are in High Supply: Read the Data New data shows a powerful link: the more dermatologists in your area, the lower your risk of dying…

Thin Skinned: Topical Steroid Safety and Legal Landmines

| Featured Articles, Latest News, Podcast Highlights, The Latest | No Comments
Just put some salve on it" sounds so innocuous one could follow up with, "what could possibly go wrong?" Never ask that. Yes, our skin is our living breathing barrier…
Journal of Drugs in Dermatology JDD Article About Surgical Outcomes of Cylindrocarcinoma Treated With Mohs Micrographic Surgery and Excision: A Systematic Review

Surgical Outcomes of Cylindrocarcinoma Treated With Mohs Micrographic Surgery and Excision: A Systematic Review

| Featured Articles, Latest News, Skin Cancer, The Latest | No Comments
Cylindrocarcinoma: Could Mohs Surgery Be the Clear-Cut Winner? Cylindrocarcinoma—a rare malignant offshoot of benign cylindromas—poses a surgical challenge due to its potential for recurrence and metastasis. While traditional excision has…
Journal of Drugs in Dermatology JDD Article About Looking for Curated Psoriasis Content? We’ve Got You Covered!

Looking for Curated Psoriasis Content? We’ve Got You Covered!

| Featured Articles, Latest News, Psoriasis, The Latest | No Comments
Explore JDDonline If you’re on the hunt for expert-led, handpicked resources on psoriasis, you’re in the right place. Whether you're brushing up on the latest treatment insights or looking for…
Journal of Drugs in Dermatology JDD Article About The Utility of Oral Polypodium Leucotomos Extract for Dermatologic Diseases: A Systematic Review

The Utility of Oral Polypodium Leucotomos Extract for Dermatologic Diseases: A Systematic Review

| Featured Articles, Latest News, The Latest | No Comments
A Fern with Far-Reaching Potential: The Role of Polypodium Leucotomos Extract in Dermatology From photoaging to pigmentary disorders, Polypodium leucotomos extract (PLE)—a botanical with notable photoprotective and anti-inflammatory properties—has emerged…
Journal of Drugs in Dermatology JDD Article About Top Chief Complaints and Diagnoses for Outpatient Dermatology Patients of Color

Top Chief Complaints and Diagnoses for Outpatient Dermatology Patients of Color

| Featured Articles, Latest News, Skin of Color, The Latest | No Comments
Did you miss it? By 2044, people with skin of color (SOC) will make up the majority of the U.S. population—but dermatology still lags behind in addressing their unique needs.…
Journal of Drugs in Dermatology JDD Article About Improvement in Skin Moisturization and Lack of Barrier Damage Following Treatment With Clascoterone Cream 1%

Improvement in Skin Moisturization and Lack of Barrier Damage Following Treatment With Clascoterone Cream 1%

| Acne, Featured Articles, Latest News, The Latest | No Comments
Acne Treatment Without the Dry-Out: Clascoterone Cream 1% Proves Gentle on the Skin Barrier Topical acne meds often come with an unfortunate side effect: dry, irritated skin that leaves patients…

New Innovations with SkinCeuticals Advanced RGN-6

| JDD Highlights, JDD Webinars, The Latest | No Comments
Active ingredients play a critical role in the efficacy and safety of cosmeceuticals. Join Dr. Corey L. Hartman, as he shares information on a new cosmeceutical formulation. This presentation will…
Journal of Drugs in Dermatology JDD Article About The State of the Clinical Management Union: A Cross-Sectional Survey of Persons With Hidradenitis Suppurativa

The State of the Clinical Management Union: A Cross-Sectional Survey of Persons With Hidradenitis Suppurativa

| Acne, Featured Articles, Latest News, The Latest | No Comments
April Issue Must-Read! Hidradenitis suppurativa (HS) isn’t just painful—it’s deeply isolating. And new data reveals why: the majority of people living with HS don’t feel heard, treated, or informed. In a…
Journal of Drugs in Dermatology JDD Article About An Algorithm Integrating Acneceuticals into the Management of Acne Vulgaris

An Algorithm Integrating Acneceuticals into the Management of Acne Vulgaris

| Acne, Featured Articles, Latest News, The Latest | No Comments
Did you miss this #acneceuticals article from April’s issue? What if your acne routine could be smarter, more personalized—and actually stick? Say hello to the new acne algorithm that’s changing…
Journal of Drugs in Dermatology JDD Article About Off-Label Management Strategies for Generalized Granuloma Annulare: What's New?

Off-Label Management Strategies for Generalized Granuloma Annulare: What’s New?

| Featured Articles, Latest News, The Latest | No Comments
Beyond the Granuloma: Rethinking Treatment Strategies for Generalized Granuloma Annulare Long considered a therapeutic challenge, generalized granuloma annulare (GGA) continues to defy many conventional treatment approaches. While topical steroids may…
Journal of Drugs in Dermatology JDD Article About Looking for Curated Atopic Derm Content? We’ve Got You Covered.

Looking for Curated Atopic Derm Content? We’ve Got You Covered!

| Atopic Dermatitis, Featured Articles, Latest News, The Latest | No Comments
Explore JDDonline If you’re on the hunt for expert-led, handpicked resources on atopic dermatitis, you’re in the right place. Whether you're brushing up on the latest treatment insights or looking…
Journal of Drugs in Dermatology JDD Article About Rituximab in the Treatment of Epidermolysis Bullosa Acquisita: A Systematic Review of the Literature

Rituximab in the Treatment of Epidermolysis Bullosa Acquisita: A Systematic Review of the Literature

| Featured Articles, Latest News, The Latest | No Comments
Could Rituximab Be the Key to Managing Epidermolysis Bullosa Acquisita? Epidermolysis bullosa acquisita (EBA) is a rare and often debilitating autoimmune blistering disease that remains notoriously difficult to manage. While…
Journal of Drugs in Dermatology JDD Article About An Innovative Cream Improves Signs and Symptoms of Dermatoporosis in Patients Aged 65 and Over

An Innovative Cream Improves Signs and Symptoms of Dermatoporosis in Patients Aged 65 and Over

| Featured Articles, Latest News, The Latest | No Comments
A Breakthrough Approach to Aging Skin: Can This Cream Combat Dermatoporosis? As skin ages, it becomes fragile, thin, and prone to bruising - a condition known as dermatoporosis, which is…

Dermatology Roundup: Dermatologist Joins Investigators at Chan Zuckerberg Biohub New York

| JDD Highlights, JDD in the Media, The Latest | No Comments
By Allison Sit Dermatologist Aimee Payne, MD, PhD, is part of the second cohort of investigators with the Chan Zuckerberg Biohub New York, a research institute that is focused on harnessing…

Racial and Ethnic Representation in Atopic Dermatitis Clinical Trials

| Atopic Dermatitis, Featured Articles, Latest News, The Latest | No Comments
Are Atopic Dermatitis Clinical Trials Becoming More Inclusive? Atopic dermatitis (AD) affects over 31 million people in the U.S., disproportionately impacting racial and ethnic minorities who often experience greater disease…
Journal of Drugs in Dermatology JDD Article About Single-Center, Open-Label Study Study to Evaluate Improvement of Hair Appearance With Novel Hair Growth Serum

Single-Center, Open-Label Study Study to Evaluate Improvement of Hair Appearance With Novel Hair Growth Serum

| Featured Articles, Hair, Latest News, The Latest | No Comments
Can a Botanical Serum Support Hair Growth? Hair thinning and loss can be frustrating, leaving many searching for effective, non-pharmaceutical solutions. A recent 6-month study explored the potential of REVIVV®, a…
Journal of Drugs in Dermatology JDD Article About Effects of a Moisturizer Containing Colloidal Oatmeal and Filaggrin Technology on Staphylococcus Species In Vitro

Effects of a Moisturizer Containing Colloidal Oatmeal and Filaggrin Technology on Staphylococcus Species In Vitro

| Featured Articles, Latest News, The Latest | No Comments
Moisturizer and Microbiome: A New Approach to AD Management? Staphylococcus aureus colonization is linked to atopic dermatitis (AD), but could topical skincare help restore balance? A moisturizer containing colloidal oatmeal and…
Journal of Drugs in Dermatology JDD About The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas. The images is of rosacea among different skin tones

Decoding Derm: What’s the Diagnosis?

| Featured Articles, Inclusive Derm Atlas, Inclusive Dermatology Atlas, Latest News, Rosacea, The Latest | No Comments
Test Your Knowledge!  Join Dr. Alexis Carrington, Chief Dermatology Resident at George Washington University, to help understand dermatologic conditions across all skin tones. Decoding Derm: What’s the Diagnosis is a…
Journal of Drugs in Dermatology JDD Article About A Retrospective Comparative Analysis of Cutaneous Adverse Reactions in GLP-1 Agonist Therapies

A Retrospective Comparative Analysis of Cutaneous Adverse Reactions in GLP-1 Agonist Therapies

| Featured Articles, Latest News, The Latest | No Comments
GLP-1 Agonists and Skin Reactions: What Dermatologists Should Know GLP-1 agonists are widely used for diabetes and weight management, but how do they impact the skin? This study reviews cutaneous…
Journal of Drugs in Dermatology JDD Article About Improvement of Hailey-Hailey Disease Following Administration of Dupilumab

Improvement of Hailey-Hailey Disease Following Administration of Dupilumab

| Featured Articles, Latest News, The Latest | No Comments
Dupilumab for Refractory Hailey-Hailey Disease Hailey-Hailey disease (HHD) is a challenging chronic skin disorder marked by painful blisters and erosions. Treatment can be difficult, with many patients experiencing recurrent flare-ups despite…
Journal of Drugs in Dermatology JDD Article About A Retrospective Comparative Analysis of Cutaneous Adverse Reactions in GLP-1 Agonist Therapies

Exploring the Therapeutic Potential of GLP-1 Agonists in Hidradenitis Suppurativa

| Featured Articles, Latest News, The Latest | No Comments
Could GLP-1 Agonists Offer a New Approach to Hidradenitis Suppurativa? Hidradenitis Suppurativa (HS)  is a challenging inflammatory skin condition often linked to obesity and metabolic dysfunction. With GLP-1 agonists gaining attention…
Journal of Drugs in Dermatology JDD About Latin America Cutaneous Oncology Management (LACOM) I: The Role of Skin Care in Oncology Patients and Survivors

April is Rosacea Awareness Month

| Acne, Featured Articles, Latest News, Oncodermatology, Rosacea, The Latest | No Comments
Spotlight on Rosacea: Beyond the Redness This National Rosacea Month April marks National Rosacea Month, a timely reminder for dermatology professionals to sharpen their diagnostic lens beyond textbook erythema. While…
Journal of Drugs in Dermatology JDD Podcast “Ask the Investigator” spotlight about the future of acne treatment, the ongoing battle against dyspigmentation, and how to manage cutaneous side effects of targeted cancer therapies.

Did You Miss These? Must-Listen JDD Podcasts on Acne, Dyspigmentation & Oncodermatology!

| Acne, Featured Articles, Latest News, Oncodermatology, The Latest | No Comments
Listen Now! Dermatology is always evolving, and if you haven’t caught the latest "Ask the Investigator" podcast episodes, you're missing out on game-changing insights! Hosted by the always-engaging Dr. Adam…

From Rags to Itches: The Evolution of Topical and Systemic Options for Pruritus

| Featured Articles, Featured Podcast, Podcast Highlights, The Latest | No Comments
Featured Podcast Life's an itch sometimes….am I right? Pruritus can pick apart the fabric of one's life as both a symptom of a primary skin disease or even as a…
The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas Online Gallery

Exploring the Full Spectrum of Dermatology: A Diverse and Inclusive Atlas Online Gallery

| Featured Articles, Latest News, The Latest | No Comments
Looking for images for your next lecture or presentation? We’ve got you covered!  In dermatology, accurate diagnosis and treatment rely heavily on recognizing how conditions present across diverse skin tones.…
Even in a world of exponentially expanding systemic options both on and off label, one fact remains: topical therapy is ALWAYS on the menu. With an unprecedented array of nonsteroidal options, understanding the underpinnings to both use them for their intended purpose, but even more fun, OOOOOOFFFFFF LLLLLLAAAAABBBBEEEELLLL (clearly a fan of off label), is paramount to patient outcomes. Be not overwhelmed I say, as the bench to bedside badass Dr. Christopher Bunick is here for all your on and off label needs. Take a break from the typical Tuesday with a topical translational deep dive into the tantalizing options as host Dr. Adam Friedman tees off with Dr. Bunick for what is certain to be a “tough” (as the kids say) podcast.

Touching on Tailored Topical for Tons of Tough Treatment Tchallenges

| Featured Articles, Featured Podcast, Podcast Highlights, The Latest | No Comments
Featured Podcast Even in a world of exponentially expanding systemic options both on and off label, one fact remains: topical therapy is ALWAYS on the menu. With an unprecedented array…
Journal of Drugs in Dermatology JDD About Spesolimab for the Treatment of Generalized Pustular Psoriasis Flares

Spesolimab for the Treatment of Generalized Pustular Psoriasis Flares

| Featured Articles, Latest News, Psoriasis, The Latest | No Comments
Did you miss this March article? Generalized pustular psoriasis (GPP) is a serious and unpredictable skin condition with limited treatment options. The Effisayil 1 trial evaluated spesolimab, a monoclonal antibody…
Journal of Drugs in Dermatology JDD About Latin America Cutaneous Oncology Management (LACOM) I: The Role of Skin Care in Oncology Patients and Survivors

Latin America Cutaneous Oncology Management (LACOM) I: The Role of Skin Care in Oncology Patients and Survivors

| Featured Articles, Latest News, Oncodermatology, The Latest | No Comments
Prioritizing Skincare in Cancer Treatment: A Latin American Initiative Cancer treatments often lead to skin-related side effects that impact quality of life and, in some cases, treatment adherence. The Latin…
Journal of Drugs in Dermatology JDD About Artificial Intelligence-Based Personalization of Treatment Regimen for Hair Loss: A 6-Month Clinical Trial

Artificial Intelligence-Based Personalization of Treatment Regimen for Hair Loss: A 6-Month Clinical Trial

| Alopecia, Featured Articles, Hair, Latest News, The Latest | No Comments
AI-Powered Personalization for Hair Loss: A Promising Alternative? With up to 50% of women and 80% of men experiencing hair loss, many turn to generic over-the-counter solutions—often with disappointing results.…
Journal of Drugs in Dermatology JDD About Efficacy and Safety of Micronized Isotretinoin Administered Once Daily Without Food in Patients With Recalcitrant Nodular Acne. Image from The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas of a darker skin tone patient with acne.

Efficacy and Safety of Micronized Isotretinoin Administered Once Daily Without Food in Patients With Recalcitrant Nodular Acne

| Acne, Featured Articles, Latest News, The Latest | No Comments
Did You Miss It? Micronized isotretinoin is an established treatment for severe nodular acne, but can it be effectively dosed once daily instead of twice? A new pilot study explores…
Journal of Drugs in Dermatology JDD About Lichen Planus Pigmentosus. Image from the Full Spectrum of Dermatology: A Diverse and Inclusive Atlas of a person with a darker skin tone with LPP.

Cracking the Code of Lichen Planus Pigmentosus

| Dyspigmentation, Featured Articles, Latest News, The Latest | No Comments
Articles from the Archives Lichen planus pigmentosus (LPP) remains one of dermatology's most enigmatic conditions—often presenting insidiously, confounding diagnoses, and challenging treatment plans. Whether it appears as diffuse gray-brown patches…
Journal of Drugs in Dermatology JDD About TikTok as a Source of Information for Seborrheic Dermatitis: A Cross-Sectional Analysis

TikTok as a Source of Information for Seborrheic Dermatitis: A Cross-Sectional Analysis

| Featured Articles, Latest News, Social and Technology, The Latest | No Comments
Seborrheic Dermatitis on TikTok: Who's Driving the Conversation? Seborrheic dermatitis (SD) is a common yet complex inflammatory skin condition, and patients are increasingly turning to social media for guidance. But…
Journal of Drugs in Dermatology JDD About The Use of Acneceuticals to Improve Acne Care: Introduction of a New Term and Review of the Literature

The Use of Acneceuticals to Improve Acne Care: Introduction of a New Term and Review of the Literature

| Acne, Featured Articles, Latest News, The Latest | No Comments
Acneceuticals: A New Era in Acne Care? Pharmaceuticals and procedures have long been the backbone of acne treatment, but over-the-counter skincare is playing an increasingly recognized role. This new paper…
Journal of Drugs in Dermatology JDD Article About Video Abstracts

Discover the Engaging JDDonline Video Abstracts!

| Featured Articles, The Latest | No Comments
JDD's Must Watch Feature At JDDonline, we're always looking for new ways to bring valuable dermatology research to life. One of the most dynamic and engaging features we offer is…
Journal of Drugs in Dermatology JDD about Alopecia Universalis: Never Give Up. Image of alopecia areata in pediatric patient.

Alopecia Universalis: Never Give Up?

| Alopecia, Featured Articles, Hair, Latest News, The Latest | No Comments
JAK Inhibitors in Alopecia Areata: A Case for Persistence? Oral Janus kinase inhibitors (JAKi) have emerged as a promising treatment for severe alopecia areata, with FDA-approved options now available. But…
Journal of Drugs in Dermatology JDD Podcast “Ask the Investigator” spotlight.

Did You Miss These? JDD’s “Ask the Investigator” Podcasts You Can’t Afford to Skip!

| Featured Articles, Featured Podcast, Latest News, The Latest | No Comments
Listen Now! If you've been snoozing on the latest JDD "Ask the Investigator" podcast episodes, consider this your wake-up call! Hosted by the ever-insightful Dr. Adam Friedman and sponsored by…
Journal of Drugs in Dermatology JDD Article About The Frequency of Non-Scarring Alopecia in Autoimmune Connective Tissue Diseases

The Frequency of Non-Scarring Alopecia in Autoimmune Connective Tissue Diseases

| Alopecia, Featured Articles, Latest News, The Latest | No Comments
Trending Article Alopecia is more than just a cosmetic concern - it’s a significant quality-of-life issue for patients with autoimmune connective tissue diseases (ACTDs) such as SLE, MCTD, Sjogren syndrome, UCTD,…
Journal of Drugs in Dermatology JDD Article About Concurrent Lichen Planopilaris and Female Androgenic Alopecia in Skin of Color: A Case Series

Concurrent Lichen Planopilaris and Female Androgenic Alopecia in Skin of Color: A Case Series

| Alopecia, Featured Articles, Hair, Latest News, The Latest | No Comments
Trichoscopy in Skin of Color: Uncovering Overlapping Alopecia Trichoscopy is a critical tool in diagnosing hair disorders, but findings can vary in skin of color, requiring a tailored approach to…
Journal of Drugs in Dermatology JDD Article About The Multifaceted Effects of Berberine: Potential Uses in Dermatology

The Multifaceted Effects of Berberine: Potential Uses in Dermatology

| Featured Articles, Latest News, The Latest | No Comments
Berberine in Dermatology: A Natural Ally for Complex Skin Conditions? Berberine, a plant-derived alkaloid long used in traditional medicine, is gaining traction as a complementary therapy in dermatology. With its…
Journal of Drugs in Dermatology JDD Article About Management of Acute Hematomas and Methods to Mitigate Risk

Management of Acute Hematomas and Methods to Mitigate Risk

| Featured Articles, Latest News, The Latest | No Comments
Post-Surgical Bleeding in Dermatology: Risk, Management, and Intervention Postoperative bleeding is one of the most common complications in dermatologic surgery, potentially leading to hematoma formation and impaired healing. While careful…
Journal of Drugs in Dermatology JDD Article About Alopecia as an Adverse Event of Immune Checkpoint Inhibitor Therapies: Clinical Evidence and Outcomes

Alopecia as an Adverse Event of Immune Checkpoint Inhibitor Therapies: Clinical Evidence and Outcomes

| Alopecia, Featured Articles, Hair, Latest News, The Latest | No Comments
ICI Therapy and Hair Loss: A Rare but Impactful Side Effect Immune checkpoint inhibitors (ICIs) have transformed cancer treatment, empowering the immune system to target tumors more effectively. But with…

Effects on the Skin Microbiome by a Moisturizer Formulated for Eczema-Prone and Sensitive Skin

| Featured Articles, Latest News, The Latest | No Comments
Microbiome Matters: Can Your Moisturizer Restore Balance? The skin microbiome is more than just a trendy buzzword - it is a critical player in the pathophysiology of atopic dermatitis and…
Journal of Drugs in Dermatology JDD Article About Social Media's Impact on Hair Loss Information Dissemination: A Systematic Review. Image from the Full Spectrum of Dermatology: A Diverse and Inclusive Atlas. Alopecia image of skin of color range from Inclusive Derm Atlas Online Gallery

Social Media’s Impact on Hair Loss Information Dissemination: A Systematic Review

| Alopecia, Featured Articles | No Comments
Did You Miss It? In December JDD posted a March article early online. If you have not read it yet, you do not want to miss it! Social media is…

Acetyl dipeptide-31 Amide: A Novel Anti-inflammatory Peptide That Demonstrates Anti-Aging, Firming, and Lifting Benefits.

| Featured Articles, The Latest, Video Abstract | No Comments
Featured Video Abstract Check out our all new video abstract from Patricia K. Farris, MD, where she discusses acetyl dipeptide-31 amide as a novel cosmetic anti-inflammatory peptide that demonstrates anti-aging,…
What a time to be a psoriasis patient, decades into the golden age of management strategies. With an embarrassment of treatment riches, all patients are clear right? Slow your roll you say? The paradigm shift has occurred and for many of our established patients it’s now about cleaning up the biologic leftovers, especially when located on far reaching and sensitive sites. How to do so? So glad you asked, as we are so fortunate Dr. Peter Lio, clinical assistant professor of dermatology and pediatrics at Northwestern, joined host Dr. Adam Friedman to provide his experiences to pick apart the NYC diner menu of topical option add-ons to our powerful buffet of advanced systemics. Make sure to come hungry!

Pspecial Psite Psoriasis Pearls: Picking the Right Combo Meal for your Patients

| Featured Articles, Featured Podcast, Podcast Highlights, Psoriasis, The Latest | No Comments
Featured Podcast What a time to be a psoriasis patient, decades into the golden age of management strategies. With an embarrassment of treatment riches, all patients are clear right? Slow…
Journal of Drugs in Dermatology JDD Article About Comparative Efficacy of Intralesional Steroid Injections vs Cryotherapy for the Treatment of Alopecia Areata

Comparative Efficacy of Intralesional Steroid Injections vs Cryotherapy for the Treatment of Alopecia Areata

| Alopecia, Featured Articles, Latest News, The Latest | No Comments
Intralesional Steroids vs. Cryotherapy: Which Wins for Alopecia Areata? Alopecia Areata (AA) remains an enigmatic condition with treatment options offering varying degrees of success. While intralesional corticosteroids are the first-line treatment,…
Journal of Drugs in Dermatology JDD Article About Effect of Recombinant Human Hyaluronidase on Conventional Hyaluronic Acid Fillers: An In Vitro Analysis

Effect of Recombinant Human Hyaluronidase on Conventional Hyaluronic Acid Fillers: An In Vitro Analysis

| Aesthetics, Featured Articles, Latest News, The Latest | No Comments
Hyaluronidase and HA Fillers: Does One Dose Fit All? Not all HA fillers dissolve the same way. A new study reveals that HA concentration is key in determining hyaluronidase effectiveness,…
Journal of Drugs in Dermatology JDD Article About Keeping Cool: An Updated Review on Cold-Induced Dermatoses and Cold-Associated Injury.

Keeping Cool: An Updated Review on Cold-Induced Dermatoses and Cold-Associated Injury

| Featured Articles, Latest News, The Latest | No Comments
Trending Article We know cold weather dries out skin, but did you know it can also cause full-blown medical conditions? Cold temperatures compromise the skin’s barrier, triggering inflammation, water loss,…
Journal of Drugs in Dermatology JDD Article About Disparities in Alopecia Areata and Vitiligo FDA Approved Therapies in Medicaid Formularies. Image from the Full Spectrum of Dermatology: A Diverse and Inclusive Atlas, a resource with side by side images of different skin tones, not just with skin of color.

Disparities in Alopecia Areata and Vitiligo FDA Approved Therapies in Medicaid Formularies

| Featured Articles, Latest News, The Latest | No Comments
Access Denied: Medicaid's Barrier to Dermatologic Treatment Vitiligo and alopecia areata (AA) are not just cosmetic concerns—they profoundly affect patients' quality of life. While the FDA has approved innovative JAK…
Journal of Drugs in Dermatology JDD Article About Differentiating and Managing Cutaneous Lupus Erythematosus-Associated Alopecia and Patchy Alopecia Areata: Therapeutic Insights From Case Studies

Differentiating and Managing Cutaneous Lupus Erythematosus-Associated Alopecia and Patchy Alopecia Areata: Therapeutic Insights From Case Studies

| Alopecia, Featured Articles, Hair, Latest News, The Latest | No Comments
Patchy Hair Loss: When Alopecia Areata Isn't the Answer Not all patchy hair loss is alopecia areata. Two recent cases reveal cutaneous lupus erythematosus (CLE) mimicking AA, highlighting a critical…
Journal of Drugs in Dermatology JDD Article About Neoadjuvant Sonidegib for the Management of Locally Advanced Basal Cell Carcinoma: A Case Report

Neoadjuvant Sonidegib for the Management of Locally Advanced Basal Cell Carcinoma: A Case Report

| Featured Articles, Latest News, Skin Cancer, The Latest | No Comments
Sonidegib for laBCC: A Neoadjuvant Game Changer? Neoadjuvant Hedgehog Pathway Inhibitors (HPIs) are reshaping the approach to locally advanced basal cell carcinoma (laBCC), but tolerability remains a concern. A recent…
Journal of Drugs in Dermatology JDD Article About The Potential Risk of Povidone-Iodine in Sperm Quality: A Case Report

The Potential Risk of Povidone-Iodine in Sperm Quality: A Case Report

| Featured Articles, Latest News, The Latest | No Comments
Featured Case Report Could your patient's go-to antiseptic be sabotaging sperm quality? PVP-I (povidone-iodine) is a trusted antimicrobial, but a recent case raises concerns about its impact on male fertility.…
Journal of Drugs in Dermatology JDD About Cancer Prevention Month. Image from the Full Spectrum of Dermatology: A Diverse and Inclusive Atlas of a darker skin tone nose or face with a pigmented basal cell carcinoma.

February: National Cancer Prevention Month

| JDD Highlights, Latest News, Skin Cancer, The Latest | No Comments
A Spotlight on Skin Health As February unfolds, so does an important reminder—this month is National Cancer Prevention Month. For dermatologists, it's a time to reinforce awareness, education, and proactive…
Journal of Drugs in Dermatology JDD Article About Antioxidant, Keratolytic, and Hydrating Treatment for Seborrheic Keratoses. Image from the Full Spectrum of Dermatology: A Diverse and Inclusive Atlas of a darker skin tone back or torso with a seborrheic keratoses.

Antioxidant, Keratolytic, and Hydrating Treatment for Seborrheic Keratoses

| Featured Articles, JDD Highlights, Latest News, The Latest | No Comments
JDD Spotlight: A Novel Topical Approach for Seborrheic Keratoses? Could a new topical formula change the way we manage seborrheic keratoses? In a pilot study, a unique blend of antioxidants,…

JDD in the News: Micropeptide Addresses Aging, Inflammation

| Acne, Derm Community, Featured Articles, JDD Highlights, JDD in the Media, The Latest | No Comments
A recent Journal of Drugs in Dermatology study about a micropeptide with anti-aging and anti-inflammatory effects made news in Dermatology Times. The study, “Acetyl Dipeptide-31 Amide: A Novel Cosmetic Anti-Inflammatory…
Journal of Drugs in Dermatology JDD Article About Guselkumab Efficacy by Psoriasis Disease Severity and Treatment History: VOYAGE 1 and 2 Post Hoc Analyses. Image from the Full Spectrum of Dermatology: A Diverse and Inclusive Atlas of a darker skin tone elbow with psoriasis.

Guselkumab Efficacy by Psoriasis Disease Severity and Treatment History: VOYAGE 1 and 2 Post Hoc Analyses

| Featured Articles, JDD Highlights, Latest News, Psoriasis, The Latest | No Comments
JDD Spotlight: Guselkumab's 5-Year Promise in Psoriasis Curious about long-term breakthroughs in psoriasis care? A recent pooled analysis from the Phase 3 VOYAGE studies hints that guselkumab might be a…

New Formulations of Acyclothymidine Dinucleosides Reduce Damaging Effects of Ultraviolet Radiation in an Ex Vivo Skin Model

| Featured Articles, The Latest, Video Abstract | No Comments
Check out our all-new JDD Video Abstract from Naiem T. Issa, MD, PhD, who discusses how new formulations of acyclothymidine dinucleosides reduces the damaging effects of ultraviolet radiation in an…
Journal of Drugs in Dermatology JDD Article About Dupilumab Treatment Improves Lichenification in Atopic Dermatitis in Different Age and Racial Groups. Image from the Full Spectrum of Dermatology: A Diverse and Inclusive Atlas. It is one of the images from a side by side comparison of full range skin tones of a hand with atopid dermatitis (AD).

Dupilumab Treatment Improves Lichenification in Atopic Dermatitis in Different Age and Racial Groups

| Atopic Dermatitis, Featured Articles, JDD Highlights, Latest News, The Latest | No Comments
JDD Spotlight: Dupilumab Shows Rapid, Sustained Relief for Lichenification in AD A new pooled analysis from five clinical trials has revealed that dupilumab significantly improves lichenification in moderate to severe…
Journal of Drugs in Dermatology JDD Article About Patient- and Clinician-Reported Outcomes for Tirbanibulin in Actinic Keratosis in Clinical Practice Across the United States (PROAK). Image is from the Full Spectrum of Dermatology: A Diverse and Inclusive Atlas of a skin tone with actinic keratosis (AK).

Patient- and Clinician-Reported Outcomes for Tirbanibulin in Actinic Keratosis in Clinical Practice Across the United States (PROAK)

| Featured Articles, Latest News, The Latest | No Comments
JDD Spotlight The PROAK study evaluated real-world outcomes in patients with actinic keratosis reated with tirbanibulin 1% ointment over 24 weeks. Early improvements in quality of life were noted as…
Journal of Drugs in Dermatology JDD Article About Oral Collagen Supplementation: A Systematic Review of Dermatological Applications.

Oral Collagen Supplementation: A Systematic Review of Dermatological Applications

| Aesthetics, Featured Articles, Latest News, The Latest | No Comments
From the Vault Do collagen supplements really work for skin? Collagen supplements are booming in the skincare world, but do they truly deliver on their promises? With little regulation around…
Journal of Drugs in Dermatology JDD in partnership with George Washington University presents a new installment of Transitional Science Lecture Series.

Translational Science Lecture Series

| Latest News, Psoriasis, The Latest | No Comments
PSO Exciting: Clinical Pearls and Emerging Therapies For Psoriasis The field of dermatology continues to evolve at a rapid pace, bringing groundbreaking research from the lab to the clinic. As…
Journal of Drugs in Dermatology JDD Article About Expert Roundtable on Skin Care Integration After Aesthetic Procedures: Consensus Recommendations.

Expert Roundtable on Skin Care Integration After Aesthetic Procedures: Consensus Recommendations

| Aesthetics, Featured Articles, Latest News, The Latest | No Comments
Trending Article Alert Integrated skincare—the future of aesthetic  outcomes? A roundtable, featured at the Thriving in Diversity webinar series, brought together leading dermatologists and cosmetic surgeons to discuss how integrated…
Journal of Drugs in Dermatology JDD Article About Assessment of the Vehicle for Roflumilast Cream Compared to a Ceramide-Containing Moisturizing Cream in Mild Eczema

Assessment of the Vehicle for Roflumilast Cream Compared to a Ceramide-Containing Moisturizing Cream in Mild Eczema

| Featured Articles, Latest News, The Latest | No Comments
Did You Miss It? How does the roflumilast cream vehicle compare? For patients with inflammatory dermatologic conditions, a hydrating vehicle is key to improving the skin barrier without irritation. But…

OAT: The Natural Maestro of the Skin Symphony

| JDD Highlights, JDD Webinars, The Latest | No Comments
Listen in on a panel discussion on the use of colloidal oat in skin care. Drs Friedman, Chovatiya, and Heath will share their insights on the history and science behind…
Journal of Drugs in Dermatology JDD Article About Self-Reported Long-Term Side Effects of Isotretinoin: A Case Series.

Self-Reported Long-Term Side Effects of Isotretinoin: A Case Series

| Featured Articles, Latest News, The Latest | No Comments
From the Vault Isotretinoin remains the gold standard for treating severe nodulocystic acne, yet concerns about its potential psychiatric effects continue to spark debate. While high-quality studies have found no…
Managing alopecia is already anxiety provoking enough, but throw some inflammatory scalp diseases into the mix…ok deep breaths…think of a happy place. So happy your brain brought you to this podcast, during which host Dr. Adam Friedman sheds both tears and pearls (or is it curls) with the incredible triple board certified Dr. Candrice Heath, Associate Professor of Dermatology at Howard University School of Medicine. Brush up on your patient engagement skills and management strategies with these two head cases to optimize your management of scalp and hair diseases for all.

Scouting the Scalp: Practical and Case-Based Approaches to Managing Hair and Scalp Diseases

| Featured Articles, Featured Podcast, Hair, Podcast Highlights, The Latest | No Comments
Featured Podcast Managing alopecia is already anxiety provoking enough, but throw some  inflammatory scalp diseases into the mix...ok deep breaths...think of a happy place. So happy your brain brought you…
Journal of Drugs in Dermatology JDD Article About Visual Assessment Tools and Therapeutic Implications for Acanthosis Nigricans. Image is from the Full Spectrum of Dermatology: A Diverse and Inclusive Atlas that features acanthosis nigricans on a patient with darker skin tone.

Visual Assessment Tools and Therapeutic Implications for Acanthosis Nigricans

| Featured Articles, Latest News, Skin of Color, The Latest | No Comments
Featured Article Acanthosis nigricans disproportionately affects individuals with darker skin tones, yet no FDA-approved treatment currently exists. As the demand for effective therapies grows, the dermatology community faces a critical challenge:…
Zoe Diana Draelos, MD, discusses the Assessment of the Vehicle for Roflumilast Cream Compared to a Ceramide-Containing Moisturizing Cream in Mild Eczema.

Assessment of the Vehicle for Roflumilast Cream Compared to a Ceramide-Containing Moisturizing Cream in Mild Eczema

| Featured Articles, The Latest, Video Abstract | No Comments
Check out our all-new JDD Video Abstract from Zoe Diana Draelos, MD, who assesses the vehicle for roflumilast cream compared to a ceramide-containing moisturizing cream in treating mild eczema.

JDD Making Headlines: GLP-1 Receptor Agonists in Dermatology

| Featured Articles, The Latest | No Comments
Featured Article Have you missed this November  2024 article that's been making headlines? GLP-1 receptor agonists (GLP1RAs), including liraglutide and semaglutide, are proving effective beyond their established roles in weight…
Journal of Drugs in Dermatology JDD Article About Self-Reported Long-Term Side Effects of Isotretinoin: A Case Series.

Insights Into Demographics, Comorbidities, and Risk Factors in Keloids and Hypertrophic Scars: A Retrospective Study

| Featured Articles, The Latest | No Comments
Featured Article Who is at risk for hypertrophic scars and keloids? A study of 6,249 patients reveals that hypertrophic scars and keloids are significantly more common in Black/African American individuals…
Journal of Drugs in Dermatology JDD Article About Evaluating Quality and Reliability of Most-Viewed TikTok Videos About Spironolactone

Evaluating Quality and Reliability of Most-Viewed TikTok Videos About Spironolactone

| Featured Articles, Social and Technology, The Latest | No Comments
Featured Article TikTok and acne: misinformation or opportunity? With TikTok's massive reach, it's a growing hub for acne education, including treatments like spironolactone. However, most content consists of unreliable patient testimonials,…
Journal of Drugs in Dermatology JDD Article About The Future of Machine Learning Enabled Technologies for Hair Loss Treatment. Image from the Full Spectrum of Dermatology: A Diverse and Inclusive Atlas. Inclusive Derm Atlas image features a patient with hair loss or androgenic alopecia.

The Future of Machine Learning Enabled Technologies for Hair Loss Treatment

| Featured Articles, Hair, Social and Technology, The Latest | No Comments
Featured Article Could the future of hair restoration lie in machine learning (ML)? This cutting-edge technology, a subset of artificial intelligence (AI), is making waves in diagnosing and treating hair…
Journal of Drugs in Dermatology JDD Article About Co-occurring Melanoma in an Active Area of Vitiligo in Skin of Color. Image from The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas which features side by side images of patients, even with skin of color, with vitiligo.

Co-occurring Melanoma in an Active Area of Vitiligo in Skin of Color

| Featured Articles, Skin of Color, The Latest | No Comments
Featured Article Could vitiligo lower melanoma risk—or might it mask it? The intricate relationship between these conditions takes a surprising turn in this compelling case of melanoma on a non-sun-exposed site…
Cancer has met its match with the rise of new targeted therapies. However with the expanding cancer busting armament comes with the baggage of new and emerging cutaneous adverse events that prevent our patients from having their chemo cake and eating it, too. Never fear as the supportive oncoderms are here….well just two, podcast host Dr. Adam Friedman and guest Dr. Jonathan Leventhal, Associate Professor of Dermatology, the Dermatology Residency Program Director and Director of the Oncodermatology Clinic at the Yale Cancer Center. Curl up with your favorite blanket and learn about the most recent multidisciplinary-guided algorithm for preventing and managing cutaneous targeted therapy related adverse events in cancer patients (as one does). From erosive stomatitis to other dermatologic complications, this podcast is packed with actionable insights to ensure your patients can focus on fighting cancer without unnecessary setbacks. You are going to want to listen up!

Treat to (Stay on) Target(ted Therapies)

| Featured Articles, Featured Podcast, Podcast Highlights, Skin Cancer, The Latest | No Comments
Featured Podcast Cancer has met its match with the rise of new targeted therapies. However with the expanding cancer busting armament comes with the baggage of new and emerging cutaneous…

Management and Prevention of Neuromodulator Complications

| Featured Articles, The Latest | No Comments
Featured Article While neuromodulators are exceptionally safe for cosmetic use, complications such as neutralizing antibody formation and eyelid ptosis can occasionally occur. Experts participating in the “Thriving in Diversity” webinar…

A Study of Glabellar Contraction Patterns in African Descendants

| Aesthetics, Featured Articles, The Latest | No Comments
Glabellar Contraction Patterns in Black Patients: Implications for Botulinum Toxin Treatment Botulinum toxin is widely used for treating dynamic glabellar lines, but contraction patterns in Black patients had not been…
Journal of Drugs in Dermatology JDD Article About Gene Analysis of Biostimulators: Poly-L-Lactic Acid Triggers Regeneration While Calcium Hydroxylapatite Induces Inflammation Upon Facial Injection.

Gene Analysis of Biostimulators: Poly-L-Lactic Acid Triggers Regeneration While Calcium Hydroxylapatite Induces Inflammation Upon Facial Injection

| Aesthetics, Featured Articles, The Latest | No Comments
Comparing Biostimulatory Agents for Skin Rejuvenation Injectable biostimulators like poly-L-lactic acid (PLLA-SCA™) and calcium hydroxylapatite (CaHA-R) are used to stimulate collagen production in aging skin, but their molecular effects differ.…
Journal of Drugs in Dermatology JDD Article About Assessing the Landscape of AI-Powered Patient Documentation in Dermatology.

Assessing the Landscape of AI-Powered Patient Documentation in Dermatology

| Featured Articles, Social and Technology | No Comments
AI-Powered Documentation: A Burnout Solution for Dermatologists Burnout among US dermatologists has surged to 49% in 2023, with administrative tasks like charting and paperwork driving professional fatigue. AI-powered patient documentation…